International Journal of Pharmaceutical Sciences and Drug Analysis
  • Printed Journal
  • Refereed Journal
  • Peer Reviewed Journal

P-ISSN: 2788-9246, E-ISSN: 2788-9254
Printed Journal   |   Refereed Journal   |   Peer Reviewed Journal

2022, Vol. 2, Issue 2, Part A

A case report on Steven Johnson syndrome


Author(s): Shamna Haris, Almaja Lekshmi, Vijitha Raj VS and Dr. Bincy Babu

Abstract: Background: Steven–Johnson syndrome (SJS) refers to a cytotoxic immune reaction that may occur due to drugs or infections which results in uncommon mucocutaneous disorder leading to the formation of blisters with detachment of skin and mucosa. Case Presentation: This case report includes the case of a 55 year old female patient who had a concurrent administration of Tab Deflazacort, Tab Hydroxychloroquine along with Ayurvedic medicines to treat rheumatoid arthritis which resulted in the development of Steven Johnson Syndrome followed by admission to the hospital for its management. Conclusion: Steven Johnson Syndrome was managed appropriately with IV steroids and antihistamines. The symptoms associated with the condition were treated accordingly and subsided.

Pages: 52-53 | Views: 233 | Downloads: 85

Download Full Article: Click Here
How to cite this article:
Shamna Haris, Almaja Lekshmi, Vijitha Raj VS, Dr. Bincy Babu. A case report on Steven Johnson syndrome. Int J Pharm Sci Drug Anal 2022;2(2):52-53.
International Journal of Pharmaceutical Sciences and Drug Analysis
Call for book chapter